Page last updated: 2024-08-23

acetylgalactosamine and Hepatitis B

acetylgalactosamine has been researched along with Hepatitis B in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harashima, H; Kohara, M; Matsui, H; Munakata, T; Sato, R; Sato, Y; Yamamoto, N	1

Other Studies

1 other study(ies) available for acetylgalactosamine and Hepatitis B

Article	Year
Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus. Journal of controlled release : official journal of the Controlled Release Society, 2017, Nov-28, Volume: 266 Topics: Acetylgalactosamine; Animals; Cytokines; DNA, Viral; Endothelial Cells; Factor VII; Female; Hepatitis B; Hepatitis B virus; Hepatocytes; Lipids; Mice, Inbred ICR; Nanoparticles; Neutrophils; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; RNA, Small Interfering	2017

Article

Year

Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus.

Journal of controlled release : official journal of the Controlled Release Society, 2017, Nov-28, Volume: 266

Topics: Acetylgalactosamine; Animals; Cytokines; DNA, Viral; Endothelial Cells; Factor VII; Female; Hepatitis B; Hepatitis B virus; Hepatocytes; Lipids; Mice, Inbred ICR; Nanoparticles; Neutrophils; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; RNA, Small Interfering

2017